Penn State University
psu.eduTotal trials
258
Active
58
Phase 3
4
Total enrollment
66,380
Read this sponsor's pipeline like an analyst.
Generate a written report: strategic focus, priority programs, pipeline shape, recent terminations and momentum, and the trials worth watching in the next 12 months.
~15-30 sec · cached for 24h
Pipeline matrix
Showing 16 of 16 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| Combined Oral Contraceptive | — | — | — | — | — | 2 | |
| Contraceptive Vaginal Ring | — | — | — | — | — | 2 | |
| Elagolix Oral | — | — | — | — | — | 1 | |
| Estradiol patch | — | — | — | — | — | 1 | |
| simvastatin 10mg | — | — | — | — | — | 1 | |
| Bazedoxifene 20/Estrogens,Con 0.45Mg Tb | — | — | — | — | — | 1 | |
| Aspirin | — | — | — | — | — | 1 | |
| Whole Egg | — | — | — | — | — | 1 | |
| Yogurt smoothie with BB-12 | — | — | — | — | — | 1 | |
| Yogurt smoothie | — | — | — | — | — | 1 | |
| Low dose ASA | — | — | — | — | — | 1 | |
| TRPM8 Agonist | — | — | — | — | — | 1 | |
| TRPV1 Agonist | — | — | — | — | — | 1 | |
| TRPV4 Agonist | — | — | — | — | — | 1 | |
| TRPM8, TRPV4, TRPV1 Agonists | — | — | — | — | — | 1 | |
| Salsalate Pill | — | — | — | — | — | 1 |
Next readouts
- 2022-10
- 2025-12-31
- 2025-12-31
- 2025-12-31
- 2026-06-01
- 2026-07
- 2026-08-01
- 2026-12
- 2027-02-27
Top conditions
- Cardiovascular Disease20
- Eating Behavior15
- Cardiovascular Diseases12
- Obesity12
- Pediatric Obesity10
- Feeding Behavior9
- Metabolic Syndrome7
- Anxiety6
Frequently asked questions about Penn State University
- How many clinical trials does Penn State University have on ClinicalTrials.gov?
- Penn State University is listed as the lead sponsor on 258 clinical trials in ClinicalTrials.gov, 58 of which are currently active (recruiting, enrolling, or ongoing).
- How many of Penn State University's trials are in Phase 3?
- 4 of Penn State University's trials are in Phase 3, spread across 16 active drug programs.
- What therapeutic areas does Penn State University focus on?
- Penn State University's most-studied conditions on ClinicalTrials.gov are Cardiovascular Disease, Eating Behavior, Cardiovascular Diseases, Obesity, Pediatric Obesity.
- When are Penn State University's next clinical trial readouts?
- Penn State University has 9 upcoming primary-completion readouts tracked here; the soonest is “Probiotics and Gut Health”, expected around 2022-10.